but whats with all these free options to directors, it isa lot and further dilution.
as they stacking up because of a likely takeover?!,
isn't that what other companies do? directors buy but don't sell to met tax obilgations, but in comes a white knights or two in battle
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-143
-
- There are more pages in this discussion • 238 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
-0.050(4.67%) |
Mkt cap ! $1.161B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.05 | $1.01 | $3.119M | 3.036M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 211647 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 30114 | 12 |
View Market Depth
| Last trade - 11.35am 30/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |